| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |